Breast Biopsies After Neoadjuvant Chemotherapy Accurately Predict Presence of Residual Breast Cancer: University of Texas
HOUSTON, Texas, Dec. 14 [TNSmedicalresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
- Protocol identifies breast cancer patients for study in which surgery may be eliminated
* * *
Researchers from The University of Texas MD Anderson Cancer Center have identified a standardized protocol that uses image-guided breast biopsies to reliably predict residual disease in breast cancer patients an . . .
* * *
- Protocol identifies breast cancer patients for study in which surgery may be eliminated
* * *
Researchers from The University of Texas MD Anderson Cancer Center have identified a standardized protocol that uses image-guided breast biopsies to reliably predict residual disease in breast cancer patients an . . .